September 4, 2020
The American Association of Colleges of Pharmacy (AACP) selected UNC Eshelman School of Pharmacy’s Kim Brouwer, Pharm.D., Ph.D., as the recipient of the 2020 Volwiler Research Achievement Award.
The award was established as the research prize in academic pharmacy to honor the late Ernest H. Volwiler, former president and research director of Abbott Laboratories. The intent of the annual award is to recognize an individual within the ranks of pharmacy education recognized by his or her peers as one of the leading research workers in a given area of the pharmaceutical and clinical sciences, pharmacy practice and the social and administrative sciences, and for outstanding contributions to the respective disciplines.
“I’m truly honored to receive AACP’s prestigious Volwiler Research Achievement Award, one of the highest honors bestowed on pharmacy educators who have made landmark contributions as researchers to the pharmaceutical sciences. In receiving this award, I want to thank all of the talented students and postdoctoral fellows who I have mentored over the years – their hard work, dedication and creativity contributed in countless ways to our discoveries,” Brouwer said.
Brouwer is the William R. Kenan Jr. Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the School of Pharmacy, associate dean for research and graduate education, and a professor in the curriculum in toxicology.
Throughout her career, which spans more than 30 years with the UNC Eshelman School of Pharmacy, she has mentored more than 100 graduate students and postdoctoral fellows as well as numerous undergraduate and professional students, and published more than 245 research papers, reviews and book chapters in addition to more than 240 published abstracts. She has also served on numerous editorial advisory boards and is decorated by several awards of excellence.
Her work focuses on hepatic drug disposition and the clinical impact of drug transport proteins. Her research team continues to develop and refine in vitro model systems and tools to predict in vivo hepatobiliary disposition, drug interactions, and hepatotoxicity.
Brouwer’s recent achievement will be honored during the AACP’s 2021 annual meeting.